ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,740 | +75.7% | 57,200 | +116.3% | 0.00% | +200.0% |
| Q2 2023 | $177,452 | +80.4% | 26,446 | +137.4% | 0.00% | 0.0% |
| Q1 2023 | $98,367 | -25.5% | 11,140 | -40.1% | 0.00% | 0.0% |
| Q3 2022 | $132,000 | -16.5% | 18,605 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $158,000 | -39.2% | 19,583 | +4.7% | 0.00% | -50.0% |
| Q1 2022 | $260,000 | -50.3% | 18,703 | +0.4% | 0.00% | -33.3% |
| Q4 2021 | $523,000 | -78.3% | 18,635 | -73.8% | 0.00% | -78.6% |
| Q3 2021 | $2,414,000 | -20.0% | 71,019 | -3.9% | 0.01% | -22.2% |
| Q2 2021 | $3,018,000 | +2.6% | 73,866 | +1.1% | 0.02% | -5.3% |
| Q1 2021 | $2,941,000 | -11.1% | 73,056 | +30.6% | 0.02% | -9.5% |
| Q4 2020 | $3,307,000 | – | 55,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |